Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

Key Points

• The aim is to enhance recognition and understanding of MOGAD in clinical practice.
• Reviewed clinical and imaging characteristics of MOGAD.
• Evaluated the utility of the MOG antibody test.
• Assessed immunotherapy approaches based on retrospective studies.
• Identified distinctive features of MOGAD on MRI and in CSF.
• Clarified the benefits and limitations of MOG antibody testing.
• Outlined current immunotherapy strategies borrowed from similar autoimmune conditions.